Poolbeg Pharma Plc Stock Analysis
| POLBF Stock | USD 0.07 0.02 55.53% |
Poolbeg Pharma's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Poolbeg Pharma's financial risk is the risk to Poolbeg Pharma stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Poolbeg Pharma's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Poolbeg Pharma is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Poolbeg Pharma to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Poolbeg Pharma is said to be less leveraged. If creditors hold a majority of Poolbeg Pharma's assets, the Company is said to be highly leveraged.
Poolbeg Pharma PLC is overvalued with Real Value of 0.0514 and Hype Value of 0.07. The main objective of Poolbeg Pharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what Poolbeg Pharma PLC is worth, separate from its market price. There are two main types of Poolbeg Pharma's stock analysis: fundamental analysis and technical analysis.
The Poolbeg Pharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Poolbeg Pharma's ongoing operational relationships across important fundamental and technical indicators.
Poolbeg |
Poolbeg Pink Sheet Analysis Notes
About 20.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom. Poolbeg Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 7 people.The quote for Poolbeg Pharma PLC is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Poolbeg Pharma PLC contact Jeremy Skillington at 44 20 7183 1499 or learn more at https://www.poolbegpharma.com.Poolbeg Pharma PLC Investment Alerts
| Poolbeg Pharma PLC is way too risky over 90 days horizon | |
| Poolbeg Pharma PLC has some characteristics of a very speculative penny stock | |
| Poolbeg Pharma PLC appears to be risky and price may revert if volatility continues | |
| Poolbeg Pharma PLC has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (3.11 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Poolbeg Pharma PLC has accumulated about 18.89 M in cash with (2.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders |
Poolbeg Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 60.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Poolbeg Pharma's market, we take the total number of its shares issued and multiply it by Poolbeg Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 12th of February 2026, Poolbeg Pharma holds the Risk Adjusted Performance of 0.1064, variance of 46.72, and Coefficient Of Variation of 812.4. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Poolbeg Pharma, as well as the relationship between them. Please check Poolbeg Pharma PLC market risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and treynor ratio to decide if Poolbeg Pharma PLC is priced some-what accurately, providing market reflects its current price of 0.0661 per share. As Poolbeg Pharma PLC appears to be a penny stock we also advise to check out its information ratio numbers.Poolbeg Pharma PLC Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Poolbeg Pharma price series with the more recent values given greater weights.
Poolbeg Pharma Predictive Daily Indicators
Poolbeg Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Poolbeg Pharma pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.56 | |||
| Day Median Price | 0.0661 | |||
| Day Typical Price | 0.0661 | |||
| Price Action Indicator | 0.0118 | |||
| Period Momentum Indicator | 0.0236 |
Poolbeg Pharma Forecast Models
Poolbeg Pharma's time-series forecasting models are one of many Poolbeg Pharma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Poolbeg Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Poolbeg Pharma Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Poolbeg Pharma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Poolbeg Pharma, which in turn will lower the firm's financial flexibility.About Poolbeg Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Poolbeg Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Poolbeg shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Poolbeg Pharma. By using and applying Poolbeg Pink Sheet analysis, traders can create a robust methodology for identifying Poolbeg entry and exit points for their positions.
Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom. Poolbeg Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 7 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Poolbeg Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Complementary Tools for Poolbeg Pink Sheet analysis
When running Poolbeg Pharma's price analysis, check to measure Poolbeg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poolbeg Pharma is operating at the current time. Most of Poolbeg Pharma's value examination focuses on studying past and present price action to predict the probability of Poolbeg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poolbeg Pharma's price. Additionally, you may evaluate how the addition of Poolbeg Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |